Crossmark

Reducing the effective dosage of Mitomycin C on a high-grade bladder cancer cell line through combination with selenium nanoparticles: An in vitro study

Crossref DOI link: https://doi.org/10.1007/s12032-025-02758-6

Published Online: 2025-05-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Oskouie, Iman Menbari

Amirzargar, Hossein

Dezfuli, Amin Shiralizadeh

Mashhadi, Rahil

Mirzaei, Akram

Shamshirgaran, Amirreza

Nikoofar, Parsa

Aghamir, Seyed Mohammad Kazem
License Information

Text and Data Mining valid from 2025-05-10

Version of Record valid from 2025-05-10
More Information

Article History

Received: 16 February 2025

Accepted: 28 April 2025

First Online: 10 May 2025

Declarations

:

: There is no conflict of interest.

Document is current

Any future updates will be listed below